That is not quite what MSB said - they only announced a DMC review of randomised patients, not another futility analysis!
They have not said anything about the nature of the review, and absent this we can only conclude that it is a routine analysis of the blinded data to see if enough events have occurred overall to ensure the trial has a chance of generating statistically significant results. These reviews are routine, but say nothing about the chances of success or failure.
And so it's not a pass or fail on the treatment at all, it's saying there are enough events occurring to justify continuation - for example if there were no cardiac events at all in the blinded data you might as well terminate the trial now!
I'm sure if the review was any more than this routine analysis MSB would have said so!
- Forums
- ASX - By Stock
- Ann: MSB Clinical Program Update For MPC-150-IM In Heart Failure
That is not quite what MSB said - they only announced a DMC...
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
55.5¢ |
Change
0.060(12.1%) |
Mkt cap ! $633.0M |
Open | High | Low | Value | Volume |
50.0¢ | 59.0¢ | 48.5¢ | $16.88M | 30.80M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 99223 | 55.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
56.0¢ | 44000 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 99223 | 0.555 |
12 | 129157 | 0.550 |
5 | 107360 | 0.545 |
16 | 329826 | 0.540 |
2 | 67148 | 0.535 |
Price($) | Vol. | No. |
---|---|---|
0.560 | 44000 | 4 |
0.565 | 310 | 1 |
0.570 | 164673 | 5 |
0.575 | 43000 | 3 |
0.580 | 226348 | 7 |
Last trade - 16.10pm 28/03/2024 (20 minute delay) ? |
|
|||||
Last
55.5¢ |
  |
Change
0.060 ( 15.7 %) |
|||
Open | High | Low | Volume | ||
50.5¢ | 59.0¢ | 48.5¢ | 11524458 | ||
Last updated 16.02pm 28/03/2024 ? |
Featured News
MSB (ASX) Chart |
The Watchlist
BGD
BARTON GOLD HOLDINGS LIMITED
Alex Scanlon, Managing Director & CEO
Alex Scanlon
Managing Director & CEO
SPONSORED BY The Market Online